Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
View graph of relations


Lung cancer.

Lung cancer radiotherapy and lung stereotactic ablative body radiotherapy (SABR).

Motion management in radiotherapy including deep inspiration breath hold radiotherapy.

Image guided radiotherapy.

Main research areas

Lung cancer radiotherapy and lung stereotactic ablative body radiotherapy (SABR).

Breathing adapted radiotherapy including deep inspiration breath hold radiotherapy.

Radiopaque markers for precision radiotherapy.

Uncertainties in radiotherapy planning and delivery.

Artifact managing in imaging for radiotherapy.

Impact of treatment uncertainties on delivered dose in proton therapy.

Current research

INHALE - prospective study of deep inspiration breath-hold radiotherapy for locally advanced non-small cell lung cancer supported by grant from the Danish Cancer Society (R90-A6009-14-S2).

BioXmark - injectable marker for radiotherapy image guidance.

HILUS - Nordic multi center study on SABR of central lung tumors.

PET-boost - European multi center study on dose escalation in radiotherapy of locally advanced non-small cell lung cancer.

Retrospective studies on survival after palliative cerebral and thoracic radiotherapy.

Retrospective studies on survival and toxicity after lunge cancer radiotherapy with curative aim.

APRIL - impact of motion management on PET/CT for radiotherapy planning.

Impact of treatment uncertainties on delivered dose in proton therapy.


Potential conflicts of interest


ID: 9781